RecruitingNot ApplicableNCT06374537

Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.

Evaluating the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.


Sponsor

University of Illinois at Chicago

Enrollment

150 participants

Start Date

May 22, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This research is being done to better understand the impact of the use of a specific physical activity training program (GH Method) in dialysis/kidney disease patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether a targeted physical activity program can improve strength, fitness, and quality of life for people with kidney disease who are physically weakened — including those on dialysis or with advanced CKD. **You may be eligible if...** - You are on dialysis, OR have stage 4 CKD (GFR 15–29), OR have stage 5 CKD (GFR below 15), OR have had a kidney transplant (for a specific subgroup) - Your healthcare provider has described you as clinically debilitated (physically weakened) - You are able to understand questionnaires and follow instructions **You may NOT be eligible if...** - You have heart or lung disease that makes physical training unsafe - You are unable to provide consent - You are unable to travel to the training center Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMuscle Therapy

Participants will attend 2 muscle therapy sessions a week for 12 months, for one hour each.


Locations(1)

University of Illinois at Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06374537


Related Trials